Koji Yada

830 total citations
47 papers, 570 citations indexed

About

Koji Yada is a scholar working on Hematology, Genetics and Surgery. According to data from OpenAlex, Koji Yada has authored 47 papers receiving a total of 570 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Hematology, 10 papers in Genetics and 5 papers in Surgery. Recurrent topics in Koji Yada's work include Hemophilia Treatment and Research (34 papers), Blood Coagulation and Thrombosis Mechanisms (23 papers) and Platelet Disorders and Treatments (19 papers). Koji Yada is often cited by papers focused on Hemophilia Treatment and Research (34 papers), Blood Coagulation and Thrombosis Mechanisms (23 papers) and Platelet Disorders and Treatments (19 papers). Koji Yada collaborates with scholars based in Japan, United States and United Kingdom. Koji Yada's co-authors include Keiji Nogami, Midori Shima, Kenichi Ogiwara, Shōgo Saito, Tatsuji Nakajima, Hiroyuki Sasabe, Shoko Furukawa, Masahiro Takeyama, Tomoko Matsumoto and Yuto Nakajima and has published in prestigious journals such as Blood, Arteriosclerosis Thrombosis and Vascular Biology and British Journal of Haematology.

In The Last Decade

Koji Yada

44 papers receiving 547 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Koji Yada Japan	12	320	95	73	73	66	47	570
Kenny M. Hansson Sweden	14	174 0.5×	54 0.6×	17 0.2×	9 0.1×	121 1.8×	38	784
J Belleville France	12	186 0.6×	39 0.4×	22 0.3×	15 0.2×	132 2.0×	37	500
Wei‐Chieh Lin Taiwan	15	20 0.1×	32 0.3×	25 0.3×	50 0.7×	61 0.9×	38	683
Jack N. Lindon United States	12	321 1.0×	23 0.2×	9 0.1×	24 0.3×	330 5.0×	30	978
EW Merrill United States	8	138 0.4×	21 0.2×	9 0.1×	10 0.1×	69 1.0×	10	441
Yusuke Araki Japan	9	406 1.3×	28 0.3×	20 0.3×	6 0.1×	124 1.9×	24	676
Rose E. Callahan United States	13	19 0.1×	17 0.2×	19 0.3×	9 0.1×	144 2.2×	27	516
J.L. Enriquez Spain	11	8 0.0×	20 0.2×	57 0.8×	69 0.9×	45 0.7×	20	374
H.P. Wendel Germany	12	54 0.2×	24 0.3×	38 0.5×	2 0.0×	147 2.2×	20	376
K K Wu United States	9	147 0.5×	43 0.5×	20 0.3×	3 0.0×	59 0.9×	21	661

Countries citing papers authored by Koji Yada

Since Specialization

Citations

This map shows the geographic impact of Koji Yada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koji Yada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koji Yada more than expected).

Fields of papers citing papers by Koji Yada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koji Yada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koji Yada. The network helps show where Koji Yada may publish in the future.

Co-authorship network of co-authors of Koji Yada

This figure shows the co-authorship network connecting the top 25 collaborators of Koji Yada. A scholar is included among the top collaborators of Koji Yada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koji Yada. Koji Yada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sakata, Asuka, Yusuke Inagaki, Suguru Harada, et al.. (2024). Force‐sensing treadmill gait analysis system can detect gait abnormalities in haemophilia patients without arthropathy. Haemophilia. 30(3). 780–790. 1 indexed citations

Yada, Koji & Keiji Nogami. (2024). Pharmacokinetic evaluation of efanesoctocog alfa: breakthrough factor VIII therapy for hemophilia A. Expert Opinion on Drug Metabolism & Toxicology. 21(1). 5–14. 2 indexed citations

Yada, Koji, et al.. (2024). Reduced plasma factor X is associated with a lack of response to recombinant activated factor VII in patients with hemophilia A and inhibitor, but does not impair emicizumab-driven hemostasis in vitro. Thrombosis Research. 237. 37–45. 2 indexed citations

Takeyama, Masahiro, Tomoko Matsumoto, Shoko Furukawa, et al.. (2021). Comprehensive blood coagulation potential in patients with acquired hemophilia A: retrospective analyses of plasma samples obtained from nationwide centers across Japan. International Journal of Hematology. 115(2). 163–172. 5 indexed citations

Yagyuu, Takahiro, et al.. (2020). Risk factors for post-extraction bleeding in patients with haemophilia: a retrospective cohort study. British Journal of Oral and Maxillofacial Surgery. 59(3). 341–346. 5 indexed citations

Yada, Koji, Keiji Nogami, Kenichi Ogiwara, et al.. (2019). Global coagulation function assessed by rotational thromboelastometry predicts coagulation-steady state in individual hemophilia A patients receiving emicizumab prophylaxis. International Journal of Hematology. 110(4). 419–430. 50 indexed citations

Yada, Koji & Keiji Nogami. (2019). <p>Spotlight on emicizumab in the management of hemophilia A: patient selection and special considerations</p>. Journal of Blood Medicine. Volume 10. 171–181. 18 indexed citations

Nakajima, Yuto, Keiji Nogami, Koji Yada, et al.. (2019). Evaluation of clinical severity in patients with type 2N von Willebrand disease using microchip-based flow-chamber system. International Journal of Hematology. 111(3). 369–377. 6 indexed citations

Nogami, Keiji, Koji Yada, Kenichi Ogiwara, et al.. (2018). Emicizumab, the bispecific antibody to factors IX/IXa and X/Xa, potentiates coagulation function in factor XI‐deficient plasma in vitro. Journal of Thrombosis and Haemostasis. 17(1). 126–137. 12 indexed citations

10.

Yada, Koji, Keiji Nogami, Takehisa Kitazawa, et al.. (2018). Emicizumab‐mediated haemostatic function in patients with haemophilia A is down‐regulated by activated protein C through inactivation of activated factor V. British Journal of Haematology. 183(2). 257–266. 14 indexed citations

11.

Nogami, Keiji, Tomoko Matsumoto, Koji Yada, et al.. (2018). Factor (F)VIII/VIIa enhances global haemostatic function in the co‐presence of bypassing agents and FVIII among patients with haemophilia A with inhibitor. British Journal of Haematology. 181(4). 528–536. 4 indexed citations

12.

Yada, Koji, Keiji Nogami, Tomoko Matsumoto, Takehisa Kitazawa, & Midori Shima. (2017). Increasing of Ternary Complex Formation By Predominant Accumulation of Factor (F)X Accompanied By Increase of Fixa Contributes to Enhancement of Clotting Function By Apcc in Combination with Emicizumab. Blood. 130. 3658–3658. 1 indexed citations

13.

Yada, Koji, Keiji Nogami, Masahiro Takeyama, et al.. (2015). Mild hemophilia A patient with novel Pro1809Leu mutation develops an anti‐C2 antibody inhibiting allogeneic but not autologous factor VIII activity. Journal of Thrombosis and Haemostasis. 13(10). 1843–1853. 4 indexed citations

14.

Furukawa, Shoko, et al.. (2015). Systematic monitoring of hemostatic management in hemophilia A patients with inhibitor in the perioperative period using rotational thromboelastometry. Journal of Thrombosis and Haemostasis. 13(7). 1279–1284. 40 indexed citations

15.

Yada, Koji, et al.. (2013). The mild phenotype in severe hemophilia A with Arg1781His mutation is associated with enhanced binding affinity of factor VIII for factor X. Thrombosis and Haemostasis. 109(6). 1007–1015. 15 indexed citations

16.

Yada, Koji, Keiji Nogami, Kenichi Ogiwara, & Midori Shima. (2013). Activated prothrombin complex concentrate (APCC)-mediated activation of factor (F)VIII in mixtures of FVIII and APCC enhances hemostatic effectiveness. Journal of Thrombosis and Haemostasis. 11(5). 902–910. 10 indexed citations

17.

Yada, Koji, Kenichi Ogiwara, Masaru Shibata, Midori Shima, & Keiji Nogami. (2011). Effects of anti-factor VIII inhibitor antibodies on factor VIIa/tissue factor-catalysed activation and inactivation of factor VIII. Thrombosis and Haemostasis. 105(6). 989–998. 7 indexed citations

18.

Kanehiro, Hiromichi, Koji Yada, Toshiya Nishikubo, et al.. (2009). A Neonate with Umbilical Arteriovenous Malformation Showing Hemorrhagic Shock from Massive Umbilical Hemorrhage. American Journal of Perinatology. 26(8). 583–586. 8 indexed citations

19.

Yada, Koji, et al.. (1995). Protective Effect of Human Macrophage Colony-Stimulating Factor on Fungal Infection (2). Kansenshogaku zasshi. 69(5). 582–589. 5 indexed citations

20.

Nakae, Takashi, et al.. (1995). Protective Effect of Human Macrophage Colony-Stimulating Factor (hM-CSF) on Fungal Infection (1). Kansenshogaku zasshi. 69(1). 60–67. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact